XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis
NYSE:XHR - New York Stock Exchange, Inc. - US9840171030 - REIT - Currency: USD
We assign a fundamental rating of 4 out of 10 to XHR. XHR was compared to 130 industry peers in the Diversified REITs industry. The financial health of XHR is average, but there are quite some concerns on its profitability. XHR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year XHR was profitable.
In the past year XHR had a positive cash flow from operations.
In multiple years XHR reported negative net income over the last 5 years.
XHR had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
XHR has a Return On Assets (0.79%) which is in line with its industry peers.
XHR's Return On Equity of 1.88% is in line compared to the rest of the industry. XHR outperforms 52.31% of its industry peers.
XHR has a Return On Invested Capital (2.70%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for XHR is in line with the industry average of 3.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.79% | ||
| ROE | 1.88% | ||
| ROIC | 2.7% |
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of XHR (2.15%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of XHR has declined.
XHR has a worse Operating Margin (8.84%) than 80.77% of its industry peers.
XHR's Operating Margin has declined in the last couple of years.
XHR's Gross Margin of 54.48% is on the low side compared to the rest of the industry. XHR is outperformed by 74.62% of its industry peers.
In the last couple of years the Gross Margin of XHR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.84% | ||
| PM (TTM) | 2.15% | ||
| GM | 54.48% |
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
2. Health
2.1 Basic Checks
XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
XHR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for XHR has been reduced compared to 5 years ago.
The debt/assets ratio for XHR has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.61, we must say that XHR is in the distress zone and has some risk of bankruptcy.
XHR has a Altman-Z score (0.61) which is in line with its industry peers.
The Debt to FCF ratio of XHR is 49.38, which is on the high side as it means it would take XHR, 49.38 years of fcf income to pay off all of its debts.
XHR has a better Debt to FCF ratio (49.38) than 64.62% of its industry peers.
XHR has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of XHR (1.17) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.17 | ||
| Debt/FCF | 49.38 | ||
| Altman-Z | 0.61 |
ROIC/WACC0.36
WACC7.58%
2.3 Liquidity
XHR has a Current Ratio of 1.02. This is a normal value and indicates that XHR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, XHR perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that XHR should not have too much problems paying its short term obligations.
XHR has a Quick ratio (1.02) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 1.02 |
3. Growth
3.1 Past
XHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.79%, which is quite good.
The earnings per share for XHR have been decreasing by -23.70% on average. This is quite bad
XHR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.57%.
Measured over the past years, XHR shows a decrease in Revenue. The Revenue has been decreasing by -1.99% on average per year.
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%87.5%
Revenue 1Y (TTM)3.57%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%8.01%
3.2 Future
The Earnings Per Share is expected to grow by 42.53% on average over the next years. This is a very strong growth
XHR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.17% yearly.
EPS Next Y243.4%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue Next Year2.19%
Revenue Next 2Y2.72%
Revenue Next 3Y3.17%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 59.91, the valuation of XHR can be described as expensive.
XHR's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.41, XHR is valued quite expensively.
The Price/Forward Earnings ratio is 46.94, which means the current valuation is very expensive for XHR.
The rest of the industry has a similar Price/Forward Earnings ratio as XHR.
XHR is valuated rather expensively when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 59.91 | ||
| Fwd PE | 46.94 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, XHR is valued a bit cheaper than 73.08% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, XHR is valued a bit cheaper than 63.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.11 | ||
| EV/EBITDA | 11.66 |
4.3 Compensation for Growth
XHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XHR's earnings are expected to grow with 42.53% in the coming years.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y36.82%
EPS Next 3Y42.53%
5. Dividend
5.1 Amount
XHR has a Yearly Dividend Yield of 3.92%. Purely for dividend investing, there may be better candidates out there.
XHR's Dividend Yield is slightly below the industry average, which is at 6.44.
Compared to an average S&P500 Dividend Yield of 2.35, XHR pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.92% |
5.2 History
The dividend of XHR decreases each year by -15.89%.
XHR has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of XHR decreased in the last 3 years.
Dividend Growth(5Y)-15.89%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
XHR pays out 166.74% of its income as dividend. This is not a sustainable payout ratio.
DP166.74%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
NYSE:XHR (7/14/2025, 2:38:05 PM)
13.18
+0.03 (+0.23%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners98.07%
Inst Owner Change0%
Ins Owners0.94%
Ins Owner Change0.04%
Market Cap1.30B
Analysts78
Price Target14.08 (6.83%)
Short Float %3.97%
Short Ratio4.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.92% |
Yearly Dividend0.47
Dividend Growth(5Y)-15.89%
DP166.74%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.68%
Min EPS beat(2)-199.01%
Max EPS beat(2)163.65%
EPS beat(4)3
Avg EPS beat(4)3.8%
Min EPS beat(4)-199.01%
Max EPS beat(4)163.65%
EPS beat(8)5
Avg EPS beat(8)60.16%
EPS beat(12)7
Avg EPS beat(12)107.12%
EPS beat(16)9
Avg EPS beat(16)83.21%
Revenue beat(2)1
Avg Revenue beat(2)1.13%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)3.88%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)3.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.46%
Revenue beat(12)5
Avg Revenue beat(12)0.59%
Revenue beat(16)9
Avg Revenue beat(16)1.91%
PT rev (1m)1.47%
PT rev (3m)-10.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)300%
EPS NY rev (1m)0%
EPS NY rev (3m)412.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 59.91 | ||
| Fwd PE | 46.94 | ||
| P/S | 1.23 | ||
| P/FCF | 45.11 | ||
| P/OCF | 6.71 | ||
| P/B | 1.08 | ||
| P/tB | 1.08 | ||
| EV/EBITDA | 11.66 |
EPS(TTM)0.22
EY1.67%
EPS(NY)0.28
Fwd EY2.13%
FCF(TTM)0.29
FCFY2.22%
OCF(TTM)1.96
OCFY14.89%
SpS10.74
BVpS12.25
TBVpS12.2
PEG (NY)0.25
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.79% | ||
| ROE | 1.88% | ||
| ROCE | 3.41% | ||
| ROIC | 2.7% | ||
| ROICexc | 2.81% | ||
| ROICexgc | 2.86% | ||
| OM | 8.84% | ||
| PM (TTM) | 2.15% | ||
| GM | 54.48% | ||
| FCFM | 2.72% |
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.99%
ROICexgc(5y)N/A
ROCE(3y)3.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.41%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.17 | ||
| Debt/FCF | 49.38 | ||
| Debt/EBITDA | 6.35 | ||
| Cap/Depr | 126.88% | ||
| Cap/Sales | 15.55% | ||
| Interest Coverage | 1.29 | ||
| Cash Conversion | 86.6% | ||
| Profit Quality | 126.64% | ||
| Current Ratio | 1.02 | ||
| Quick Ratio | 1.02 | ||
| Altman-Z | 0.61 |
F-Score6
WACC7.58%
ROIC/WACC0.36
Cap/Depr(3y)167.19%
Cap/Depr(5y)114.68%
Cap/Sales(3y)21.77%
Cap/Sales(5y)17.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.79%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%87.5%
EPS Next Y243.4%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue 1Y (TTM)3.57%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%8.01%
Revenue Next Year2.19%
Revenue Next 2Y2.72%
Revenue Next 3Y3.17%
Revenue Next 5YN/A
EBIT growth 1Y3.25%
EBIT growth 3YN/A
EBIT growth 5Y-8.94%
EBIT Next Year188.72%
EBIT Next 3Y48.07%
EBIT Next 5YN/A
FCF growth 1Y-73.85%
FCF growth 3Y37.05%
FCF growth 5YN/A
OCF growth 1Y4.85%
OCF growth 3Y58.91%
OCF growth 5Y-7.87%